e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Preliminary data on precision of QuantiFERON-TB Plus performance
Cirillo Daniela Maria, Barcellini Lucia, Goletti Delia
Source:
Eur Respir J 2016; 48: 955-956
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cirillo Daniela Maria, Barcellini Lucia, Goletti Delia. Preliminary data on precision of QuantiFERON-TB Plus performance. Eur Respir J 2016; 48: 955-956
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
First independent evaluation of QuantiFERON-TB Plus performance
Source: Eur Respir J 2016; 47:1587-1590
Year: 2016
First evaluation of QuantiFERON-TB Gold Plus performance in contact screening
Source: Eur Respir J 2016; 48: 1411-1419
Year: 2016
Short-term reproducibility of the QuantiFERON-TB gold in-tube assay
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019
QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool
Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016
Year: 2017
The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Using QuantiFERON-TB gold in-tube in contact tracing procedures
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
The QuantiFERON-TB Gold test at HIV patients
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step?
Source: Eur Respir J 2015; 46: 1506-1509
Year: 2015
Evaluation of usefulness of QuantiFERON®-TB Gold for infants
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Year: 2017
Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Practical use of quantiferon test in Norway‘s largest TB-clinic
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts
Source: Eur Respir J 2008; 32: 524-525
Year: 2008
Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting
Source: ERJ Open Res, 7 (4) 00511-2021; 10.1183/23120541.00511-2021
Year: 2021
A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
Effects of shaking methods of blood collection tubes on QuantiFERON®-TB Gold In-Tube assays
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
QuantiFERON-TB gold in tube method in sarcoidosis patients
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test
Source: Eur Respir Rev 2008; 17: 74-75
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept